SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.85 |
| Enterprise Value ($M) | 6.16 |
| Book Value ($M) | -0.41 |
| Book Value / Share | -0.07 |
| Price / Book | -9.48 |
| NCAV ($M) | -0.59 |
| NCAV / Share | -0.10 |
| Price / NCAV | -6.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -12.50 |
| Return on Assets (ROA) | -0.91 |
| Return on Equity (ROE) | -1.41 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.30 |
| Current Ratio | 1.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.53 |
| Assets | 3.72 |
| Liabilities | 4.12 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 4.99 | -27.14 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,098 | 13,090 | 23.67 | |
| 558 | 19,471 | 2.87 | |
| 5,528 | 13,277 | 41.64 | |
| 20,447 | 40,288 | 50.75 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GRCE – Grace Therapeutics, Inc. | GTBP – GT Biopharma, Inc. |
| GYRE – Gyre Therapeutics, Inc. | HOOK – HOOKIPA Pharma Inc. |
| HOTH – Hoth Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io